Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:48 PM
Ignite Modification Date:
2025-12-24 @ 2:48 PM
NCT ID:
NCT00714259
Eligibility Criteria:
Inclusion Criteria:
* Stage II or III non-progressive disease Multiple Myeloma.
* CLL/SLL, and low grade Hodgkin Lymphomas that are in a very good partial response or complete response with non-progressive disease.
* ≤ 70 years old.
* Eligible and willing HLA matched related donor.
* Bilirubin \<2xULN.
* ALT and AST \<3xULN.
* LVEF \> 40%.
* Creatinine Clearance \>40mL/min.
* Pulmonary function DLCO corrected to ≥ 70%.
* Minimum performance score of 70%.
* Platelet count \>130 x103 micro L.
* LDH ≤1.5xULN.
* No proceeding co-morbid condition that significantly increases the risk of severe regimen related toxicity.
* No uncontrolled infections.
Exclusion Criteria:
* Age \>70 years old.
* Performance status \<70%.
* Uncontrolled infections or is HIV positive
* Prior malignancies that are felt to have a \<80% probability of being cured.
* Pregnant, breastfeeding, or refuse to use contraceptive techniques during and for 12 months following transplant.
* Prior Allograft
* History of rapidly growing disease at diagnosis or at any progression or have MDS.
* No eligible and willing HLA matched donor.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Maximum Age:
70 Years
Study:
NCT00714259
Study Brief:
Protocol Section:
NCT00714259